✦ LIBER ✦

Psychologigal well-being and gastrointestinal symptoms in inflammatory bowel disease in remission

✍ Scribed by Magnus Simren; Jenny Axelsson; Hasse Abrahamsson; Jan Svedlund; Einar S. Bjšrnsson

Book ID: 119425684
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 179 KB
Volume: 118
Category: Article
ISSN: 0016-5085
DOI: 10.1016/s0016-5085(00)82564-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Deep Remission in Inflammatory Bowel Dis

Deep Remission in Inflammatory Bowel Disease: Looking Beyond Symptoms

✍ Zallot, Camille; Peyrin-Biroulet, Laurent 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 172 KB

Extraintestinal Symptoms in Irritable Bo

Extraintestinal Symptoms in Irritable Bowel Syndrome and Inflammatory Bowel Diseases: Nature, Severity, and Relationship to Gastrointestinal Symptoms

✍ Joseph Zimmerman 📂 Article 📅 2003 🏛 Springer US 🌐 English ⚖ 53 KB

Symptoms of irritable bowel syndrome in

Symptoms of irritable bowel syndrome in inflammatory bowel disease in remission and relation-ship to psychological factors

✍ Sirnren, Magnus; Axelsson, Jenny; Abrahamsson, Hasse; Svedlund, Jan; Bjsmsson, E 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 335 KB

Gastrointestinal symptoms in first-degre

Gastrointestinal symptoms in first-degree relatives of patients with inflammatory bowel disease

✍ Scott Harris, M. 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 206 KB

Pattern of gastrointestinal symptoms acr

Pattern of gastrointestinal symptoms across the menstrual cycle in inflammatory bowel disease patients

📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 167 KB

Stopping immunomodulators and biologics

Stopping immunomodulators and biologics in inflammatory bowel disease patients in remission

✍ Kofi Clarke; Miguel Regueiro 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB

The emergence of biologic response modifiers and earlier use of immunomodulators for inflammatory bowel disease (IBD) patients have improved outcomes. Durable remissions have been achieved in many IBD patients on these treatments, but the duration of treatment and identifying which patients may stop